ProQR Therapeutics NV (PRQR)
3.64
+0.01
(+0.28%)
USD |
NASDAQ |
Nov 05, 14:50
ProQR Therapeutics Shareholders Equity (Quarterly): 35.22M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 35.22M |
| March 31, 2024 | 37.60M |
| December 31, 2023 | 45.75M |
| September 30, 2023 | 49.05M |
| June 30, 2023 | 56.28M |
| March 31, 2023 | 64.34M |
| December 31, 2022 | 71.92M |
| September 30, 2022 | 63.81M |
| June 30, 2022 | 91.26M |
| March 31, 2022 | 112.54M |
| December 31, 2021 | 128.88M |
| September 30, 2021 | 149.17M |
| June 30, 2021 | 140.55M |
| March 31, 2021 | 58.30M |
| December 31, 2020 | 70.22M |
| September 30, 2020 | 80.57M |
| June 30, 2020 | 90.08M |
| March 31, 2020 | 90.30M |
| December 31, 2019 | 105.66M |
| September 30, 2019 | 65.50M |
| June 30, 2019 | 80.31M |
| Date | Value |
|---|---|
| March 31, 2019 | 91.11M |
| December 31, 2018 | 106.29M |
| September 30, 2018 | 119.19M |
| June 30, 2018 | 26.44M |
| March 31, 2018 | 36.43M |
| December 31, 2017 | 47.22M |
| September 30, 2017 | 38.58M |
| June 30, 2017 | 42.08M |
| March 31, 2017 | 48.88M |
| December 31, 2016 | 56.17M |
| September 30, 2016 | 68.92M |
| June 30, 2016 | 78.90M |
| March 31, 2016 | 90.89M |
| December 31, 2015 | 98.18M |
| September 30, 2015 | 107.60M |
| June 30, 2015 | 114.00M |
| March 31, 2015 | 119.05M |
| December 31, 2014 | 133.04M |
| September 30, 2014 | 141.10M |
| June 30, 2014 | 46.42M |
| December 31, 2013 | -0.1229M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
35.22M
Minimum
Jun 2024
149.17M
Maximum
Sep 2021
81.13M
Average
71.92M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| uniQure NV | 97.11M |
| Merus NV | 703.26M |
| argenx SE | -- |
| Pharming Group | 225.79M |
| Pharvaris NV | 356.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.54M |
| Total Liabilities (Quarterly) | 91.32M |
| Debt to Equity Ratio | 0.1351 |
| Current Ratio | 2.730 |
| Net Debt Paydown Yield | 0.34% |